Published by Abigail Townsend on 17th September 2025
(Sharecast News) - AstraZeneca said on Monday that asthma drug Fasenra had failed to meet core targets in trials involving patients with severe lung disease.
URL: http://www.digitallook.com/dl/news/story/35359123/...